series-c-plus
Stage
1
Investors
About
Pulnovo develops novel therapies targeting pulmonary diseases by leveraging inhaled effective drug delivery platforms.
Explore Pulnovo's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.